335 related articles for article (PubMed ID: 16007641)
1. Burden of illness in Parkinson's disease.
Huse DM; Schulman K; Orsini L; Castelli-Haley J; Kennedy S; Lenhart G
Mov Disord; 2005 Nov; 20(11):1449-54. PubMed ID: 16007641
[TBL] [Abstract][Full Text] [Related]
2. A comparison of health-care costs involved in treating people with and without Parkinson's disease in Southern Sydney, New South Wales, Australia.
Cordato DJ; Schwartz R; Abbott E; Saunders R; Morfis L
J Clin Neurosci; 2006 Jul; 13(6):655-8. PubMed ID: 16797991
[TBL] [Abstract][Full Text] [Related]
3. Costs of Parkinson's disease in eastern Europe: a Czech cohort study.
Winter Y; von Campenhausen S; Brozova H; Skoupa J; Reese JP; Bötzel K; Eggert K; Oertel WH; Dodel R; Ruzicka E
Parkinsonism Relat Disord; 2010 Jan; 16(1):51-6. PubMed ID: 19665915
[TBL] [Abstract][Full Text] [Related]
4. Direct medical costs associated with Parkinson's disease: a population-based study.
Leibson CL; Long KH; Maraganore DM; Bower JH; Ransom JE; O'Brien PC; Rocca WA
Mov Disord; 2006 Nov; 21(11):1864-71. PubMed ID: 16977632
[TBL] [Abstract][Full Text] [Related]
5. Economic burden of metastatic bone disease in the U.S.
Schulman KL; Kohles J
Cancer; 2007 Jun; 109(11):2334-42. PubMed ID: 17450591
[TBL] [Abstract][Full Text] [Related]
6. Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries.
Noyes K; Liu H; Li Y; Holloway R; Dick AW
Mov Disord; 2006 Mar; 21(3):362-72. PubMed ID: 16211621
[TBL] [Abstract][Full Text] [Related]
7. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH
Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249
[TBL] [Abstract][Full Text] [Related]
8. Resource use and costs in a Swedish cohort of patients with Parkinson's disease.
Hagell P; Nordling S; Reimer J; Grabowski M; Persson U
Mov Disord; 2002 Nov; 17(6):1213-20. PubMed ID: 12465059
[TBL] [Abstract][Full Text] [Related]
9. [Impact of motor and non-motor symptoms on the direct costs of Parkinson's disease].
Cubo E; Martínez Martin P; González M; Frades B;
Neurologia; 2009; 24(1):15-23. PubMed ID: 19003550
[TBL] [Abstract][Full Text] [Related]
10. Economic burden of Parkinson's disease in a developing country: a retrospective cost analysis in Shanghai, China.
Wang G; Cheng Q; Zheng R; Tan YY; Sun XK; Zhou HY; Ye XL; Wang Y; Wang Z; Sun BM; Chen SD
Mov Disord; 2006 Sep; 21(9):1439-43. PubMed ID: 16773620
[TBL] [Abstract][Full Text] [Related]
11. Healthcare utilization and costs of patients with rosacea in an insured population.
Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
[TBL] [Abstract][Full Text] [Related]
12. The current and projected economic burden of Parkinson's disease in the United States.
Kowal SL; Dall TM; Chakrabarti R; Storm MV; Jain A
Mov Disord; 2013 Mar; 28(3):311-8. PubMed ID: 23436720
[TBL] [Abstract][Full Text] [Related]
13. Estimation of total incremental health care costs in patients with atrial fibrillation in the United States.
Kim MH; Johnston SS; Chu BC; Dalal MR; Schulman KL
Circ Cardiovasc Qual Outcomes; 2011 May; 4(3):313-20. PubMed ID: 21540439
[TBL] [Abstract][Full Text] [Related]
14. Health and economic burden of metabolic comorbidity among individuals with bipolar disorder.
Centorrino F; Mark TL; Talamo A; Oh K; Chang J
J Clin Psychopharmacol; 2009 Dec; 29(6):595-600. PubMed ID: 19910727
[TBL] [Abstract][Full Text] [Related]
15. Health care costs associated with posttraumatic stress disorder symptoms in women.
Walker EA; Katon W; Russo J; Ciechanowski P; Newman E; Wagner AW
Arch Gen Psychiatry; 2003 Apr; 60(4):369-74. PubMed ID: 12695314
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and cost of medication nonadherence in Parkinson's disease: evidence from administrative claims data.
Davis KL; Edin HM; Allen JK
Mov Disord; 2010 Mar; 25(4):474-80. PubMed ID: 20131374
[TBL] [Abstract][Full Text] [Related]
17. The annual impact of seasonal influenza in the US: measuring disease burden and costs.
Molinari NA; Ortega-Sanchez IR; Messonnier ML; Thompson WW; Wortley PM; Weintraub E; Bridges CB
Vaccine; 2007 Jun; 25(27):5086-96. PubMed ID: 17544181
[TBL] [Abstract][Full Text] [Related]
18. Annual direct and indirect health care costs of chronic idiopathic urticaria: a cost analysis of 50 nonimmunosuppressed patients.
Delong LK; Culler SD; Saini SS; Beck LA; Chen SC
Arch Dermatol; 2008 Jan; 144(1):35-9. PubMed ID: 18209166
[TBL] [Abstract][Full Text] [Related]
19. Drug and treatment costs in Parkinson's disease patients in Sweden.
Lökk J; Borg S; Svensson J; Persson U; Ljunggren G
Acta Neurol Scand; 2012 Feb; 125(2):142-7. PubMed ID: 21470194
[TBL] [Abstract][Full Text] [Related]
20. Social-economic costs and quality of life of Alzheimer disease in the Canary Islands, Spain.
Lopez-Bastida J; Serrano-Aguilar P; Perestelo-Perez L; Oliva-Moreno J
Neurology; 2006 Dec; 67(12):2186-91. PubMed ID: 17190942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
